Search results for: microscopic polyangiitis

ACR/ARHP Annual Meeting 2012: Cyclophosphamide and Rituximab Both Viable Treatment Options for ANCA-Associated Vasculitis

Mary Beth Nierengarten | February 1, 2013

Rituximab established as the drug of choice in patients with severe disease relapse, though cyclophosphamide may still play an important role for some patients, say rheumatologists

Maintenance of Remission in ANCA-Associated Vasculitis

Paul A. Monach, MD, PhD | September 5, 2012

Relapses are common, but difficult to predict and prevent.

ACR/ARHP Annual Scientific Meeting Plenary Highlights Targets and Treatments for Several Diseases

Vanessa Caceres | April 6, 2012

Promising therapeutic targets for rheumatic diseases were the focus of a plenary session here at the ACR/ARHP 2011 Annual Scientific Meeting in November. Presenters discussed discoveries and treatments for systemic sclerosis, rheumatoid arthritis, vasculitis, and Behçet’s disease.

How a Nuclear Molecule Alarms the Immune System

Deena A. Abdulahad, MD, and Marc Bijl, MD | August 1, 2011

The role of HMGB1 in the pathogenesis of lupus nephritis

The Granulomatosis of Wegener’s

Wolfgang L. Gross, MD, PhD, Antje Mueller, PhD, and Julia Holle, MD | May 16, 2011

Delving deeper into the nonvasculitis aspects of the disease

A Review of Wegener’s Treatment Data

Vanessa Caceres | January 17, 2011

Clinical trials show changing role of existing treatment and introduction of newer medications

Reading Rheum

Eric Schned, MD; Michael M. Ward, MD | April 1, 2009

Handpicked Reviews of Contemporary Literature

Wegener’s Granulomatosis Treatment Today

Carol A. Langford, MD MHS | October 1, 2008

WG has an evolving prognosis and treatment course

Case Report: Migratory Polyarthritis as the Presenting Symptom of GPA

Adil Vural, MD, & Kinanah Yaseen, MD | May 9, 2023

Granulomatosis with polyangiitis (GPA) is a primary, necrotizing granulomatous vasculitis, involving small- to medium-sized arteries, that causes systemic disease. Almost any organ can be affected, but the most affected systems are the upper airways, lungs, kidneys, eyes and peripheral nerves. Migratory polyarthritis is reported in approximately 25% of patients with anti-neutrophil cytoplasmic antibody (ANCA) associated…

Case Report: A COVID-19 Mimic

Andrea Ramirez-Gomez, MD, & Katherine Kougias Temprano, MD | September 11, 2020

A 67–year-old white woman with primary Raynaud’s phenomenon presented following a week of progressively worsening shortness of breath, dry cough and generalized malaise. An avid tennis player, she first noticed dyspnea while playing, but a few days later grew short of breath even at rest. She went to an urgent care center, where a computed…